The main issue to me was the rate of patient withdrawal due to side effects.
Also, it appears that two of the neoplasias occurred in patients who had been on mipomersen for less than a month. It would be extremely unlikely that the mipomersen caused these neoplasias.
Again, this means absolutely nothing to ANP's treatments - but evidently means a lot to its SP.
- Forums
- ASX - By Stock
- PER
- kynamro: the malignancies are a “new concern”
kynamro: the malignancies are a “new concern”, page-60
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $64.91M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.0¢ | $44.32K | 616.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4250 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 49809 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4250 | 0.071 |
1 | 50000 | 0.070 |
2 | 28090 | 0.069 |
3 | 34205 | 0.068 |
2 | 109310 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 49809 | 1 |
0.073 | 35755 | 1 |
0.075 | 13371 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online